1. Cardiovascular Safety Profile of Dapoxetine during the Premarketing Evaluation

   • Peter R. Kowey
   • Ramagopal V. Mudumbi
   • Peter M. DiBattiste

   Current Opinion Open access 27 November 2012 Pages: 1 - 11

   

2. Intra-Articular Injections for the Treatment of Osteoarthritis

   • Tommaso Iannitti
   • Daniele Lodi
   • Beniamino Palmieri

   Review Article Open access 27 November 2012 Pages: 13 - 27

   

3. Different Doses of Palonosetron for the Prevention of Postoperative Nausea and Vomiting in Children Undergoing Strabismus Surgery

   • Cihangir Bicer
   • Recep Aksu
   • Adem Boyaci

   Original Research Article Open access 27 November 2012 Pages: 29 - 36

   

4. Pharmacokinetic Drug Interactions with Vandetanib during Coadministration with Rifampicin or Itraconazole

   • Paul Martin
   • Stuart Oliver
   • Thierry Duvauchelle

   Original Research Article Open access 27 November 2012 Pages: 37 - 51

   

5. Comparison of Dissolution Profiles and Serum Concentrations of Two Lamotrigine Tablet Formulations

   • Mladena Lalic
   • Ana Pilipovic
   • Jelena Cvejic

   Original Research Article Open access 27 November 2012 Pages: 53 - 60

   

6. Comparison of the Pharmacokinetic and Pharmacodynamic Profiles of One US-Marketed and Two European-Marketed Epoetin Alfas

   • Michael Lissy
   • Marité Ode
   • Karsten Roth

   Original Research Article Open access 27 November 2012 Pages: 61 - 75

   

7. Pharmacokinetic Profile of Lesogaberan (AZD3355) in Healthy Subjects

   • Mohammad Niazi
   • Stanko Skrtic
   • Ann A. Holmberg

   Original Research Article Open access 27 November 2012 Pages: 77 - 83

   

8. Brentuximab Vedotin

   Adis R&D Profile Open access 27 November 2012 Pages: 85 - 95

   

9. Consistent Biochemical Data are Essential for Comparability of Botulinum Toxin Type A Products

   • Andy Pickett

   Correspondence Open access 27 November 2012 Pages: 97 - 98

10. Author’s Reply

    • Jürgen Frevert

    Correspondence Open access 27 November 2012 Pages: 98 - 99